Citizens & Northern Corp’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,289
Closed -$1.92M 104
2020
Q4
$1.92M Sell
12,289
-29
-0.2% -$4.53K 0.85% 35
2020
Q3
$1.41M Sell
12,318
-116
-0.9% -$13.3K 0.75% 45
2020
Q2
$1.4M Sell
12,434
-603
-5% -$67.7K 0.68% 47
2020
Q1
$1.17M Buy
13,037
+5,739
+79% +$515K 0.74% 43
2019
Q4
$789K Sell
7,298
-5,922
-45% -$640K 0.39% 62
2019
Q3
$1.3M Sell
13,220
-479
-3% -$46.9K 0.71% 48
2019
Q2
$1.79M Sell
13,699
-309
-2% -$40.5K 1% 33
2019
Q1
$1.89M Buy
14,008
+3,034
+28% +$410K 1.06% 30
2018
Q4
$1.07M Sell
10,974
-2,272
-17% -$221K 0.74% 44
2018
Q3
$1.84M Sell
13,246
-160
-1% -$22.2K 1.25% 31
2018
Q2
$1.66M Buy
13,406
+726
+6% +$90.1K 1.18% 32
2018
Q1
$1.41M Buy
12,680
+3,692
+41% +$411K 1.05% 39
2017
Q4
$1.08M Buy
8,988
+529
+6% +$63.3K 0.76% 53
2017
Q3
$1.19M Buy
8,459
+768
+10% +$108K 0.9% 49
2017
Q2
$936K Buy
+7,691
New +$936K 0.74% 55